Suppr超能文献

疼痛医学临床医生对阿片危机的看法。

Perspectives on the opioid crisis from pain medicine clinicians.

机构信息

Clinical Professor, Department of Neurology, University of North Carolina, United States.

Professor, Rush University Medical College, Departments of Anesthesiology, Family Medicine, Pharmacology, Clinical Pharmacologist Department of Anesthesiology, Pain Centers of Skokie and Evanston Hospitals, NorthShore University Health System, IL, United States.

出版信息

Dis Mon. 2018 Oct;64(10):451-466. doi: 10.1016/j.disamonth.2018.07.002. Epub 2018 Sep 18.

Abstract

Patients experiencing a terminal drug related event reflect a sentinel event. If this pharmacotherapy is a widely used agent, it may be viewed as a catastrophic problem. If patients are dying from illegal drug use when the medical establishment fails them by withdrawing or minimizing their medically prescribed medication, then the burden rests with their health care providers, legislation, and insurance carriers to actively participate in a collegial fashion to achieve parity. Causing a decay in functionality in previously functional patients, may occur with appropriately prescribed opioid medications addressing non-cancer pain when withdrawing or diminishing either with or without patient consent. The members of the medical profession have diminished their prescribing of opioids for their patients out of apparent fear of reprisal, state or federal government sanctions, and other concerned groups. Diminishing former dosages or deleting the opioid medication, preferably in concert with the patient, often results in inequitable patient care. Enforcing sanctioned decreases or ceasing to prescribe from their former required/established opioid medications precipitate patient discord. In absence of opioid misuse, abuse, diversion or addiction based upon medical "guidelines" and with a poor foundation of Evidence Based Medicine the CDC guidelines, it may be masked as a true guideline reflecting a decrement of clinical judgment, wisdom, and compassion. This article also discusses the role of pharmacy chains, insurance carriers, and their pharmacy benefit managers (PBMs) contribution to this multidimensional problem. There may be a potential solution, identified in this paper, if all the associated political, medical and insurance groups work cohesively to improve patient care. This article and the CDC guidelines are not focused at hospice, palliative, end of life care pain management.

摘要

患者出现与药物相关的终末事件反映了一个警戒事件。如果这种药物治疗是一种广泛使用的药物,那么它可能被视为一个灾难性的问题。如果患者因医疗保健机构撤回或减少他们的医疗处方药物而死于非法药物使用,那么医疗保健提供者、立法机构和保险公司就有责任以合作的方式积极参与,以实现平等。在适当的阿片类药物处方治疗非癌性疼痛时,无论是在患者同意的情况下还是不同意的情况下,撤回或减少药物剂量都可能导致原本功能正常的患者的功能下降。由于明显害怕报复、州或联邦政府的制裁以及其他有关团体的制裁,医疗专业人员减少了为患者开具阿片类药物的处方。减少以前的剂量或删除阿片类药物,最好与患者一起进行,通常会导致患者护理的不平等。根据医疗“指南”和基于循证医学的证据基础,强制减少或停止开具以前所需/规定的阿片类药物会导致患者的不满。如果没有基于医学“指南”的阿片类药物滥用、误用、转移或成瘾,并且没有循证医学的良好基础,那么这些指南可能会掩盖真正的指南,反映出临床判断、智慧和同情心的下降。本文还讨论了连锁药店、保险公司及其药房福利管理机构(PBM)在这一多层面问题中的作用。如果所有相关的政治、医疗和保险团体共同努力改善患者护理,那么本文提出的潜在解决方案可能会得到解决。本文和疾病预防控制中心的指南并不是针对临终关怀、姑息治疗、生命末期疼痛管理的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验